Secondary cancer risk estimation in paediatric cancer patients following radiotherapy
- Prosjektnummer
- 911759
- Ansvarlig person
- Camilla Hanquist Stokkevåg
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskerutdanning - dr.grad
- Helsekategori
- Cancer
- Forskningsaktivitet
- 5. Treatment Developement, 6. Treatment Evaluation
Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy.
Radiother Oncol 2016 Aug;120(2):300-6. Epub 2016 jul 13
PMID: 27424291 - Inngår i doktorgradsavhandlingen
Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer.
Acta Oncol 2015 Oct;54(9):1317-25. Epub 2015 jul 31
PMID: 26230629 - Inngår i doktorgradsavhandlingen
Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy.
Acta Oncol 2014 Aug;53(8):1048-57. Epub 2014 jul 14
PMID: 25017376 - Inngår i doktorgradsavhandlingen
Design and characterization of an SRAM-based neutron detector for particle therapy
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment Volume 804, 21 December 2015, Pages 64–71, 2015
Secondary Cancer Risk Estimates for cranio-spinal irradiation with electron, photon and proton therapy
ESTRO 33: International congress on radiotherapy & oncology. Vienna, Austria 4-8 April 2014
Estimated risk of radiation-induced lung cancer in paediatric patients following electron, photon and proton therapy.
Proceedings of the Annual Meeting for the Particle Therapy Cooperative Group (PTCOG) Shanghai, China 8-14 June 2014. Int J Particle Ther Published 08 Sep 2014
Estimating Second Cancer Risk Following Radiation Therapy
MedFys Kvitfjell 6 januar 2013
Preparations for a particle therapy facility in Norway
HITSRS 2013 Symposium, Chiba, Japan 14-19 May 2013
Simulations of the effects of organ motion on target coverage in proton therapy of prostate cancer
2nd ESTRO forum: International congress on radiotherapy & oncology. Geneva, Switzerland 19-23 April 2013
Second cancer risk estimation in radiotherapy
Fysikermøtet UiB, Bergen, 9. August 2013
Model-based predictions of secondary cancer and late effect risks following particle therapy
- Disputert:
- september 2016
- Hovedveileder:
- Ludvig Paul Muren
Measurements and Monte Carlo Simulations of Neutron Doses from Radiation Therapy with Photons, Protons and Carbon Ions
- Disputert:
- desember 2013
- Hovedveileder:
- Dieter Röhrich
- Marianne Brydøy Prosjektdeltaker
- Liv Bolstad Hysing Prosjektdeltaker
- Grete May Engeseth Prosjektdeltaker
- Kristian Ytre-Hauge Medveileder
- Ludvig Paul Muren Hovedveileder
- Camilla Stokkevåg Ph.d.-kandidat
- Eivind Rørvik Ph.d.-kandidat
- Naruhiro Matsufuji Prosjektdeltaker
- Sara Thørnqvist Postdoktor
- Mai Fukahori Prosjektdeltaker
- Jørgen Breede Baltzer Petersen Prosjektdeltaker
- Dieter Røhrich Hovedveileder
- Odd Harald Odland Medveileder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest